|
YIPF4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.318460E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.526470E-02 |
| Normal-vs-Stage2 |
2.615600E-03 |
| Normal-vs-Stage3 |
9.437300E-04 |
| Normal-vs-Stage4 |
1.93485999999687E-05 |
| Stage1-vs-Stage2 |
2.145200E-01 |
| Stage1-vs-Stage3 |
1.809170E-01 |
| Stage1-vs-Stage4 |
1.196440E-02 |
| Stage2-vs-Stage3 |
7.988800E-01 |
| Stage2-vs-Stage4 |
3.033200E-01 |
| Stage3-vs-Stage4 |
1.414790E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.784200E-04 |
| Normal-vs-AfricanAmerican |
1.341840E-01 |
| Normal-vs-Asian |
3.742700E-03 |
| Caucasian-vs-AfricanAmerican |
4.173000E-01 |
| Caucasian-vs-Asian |
9.348000E-01 |
| AfricanAmerican-vs-Asian |
3.988400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.415320E-03 |
| Normal-vs-Female |
2.440500E-03 |
| Male-vs-Female |
4.871200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.226500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.973300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.376700E-04 |
| Normal-vs-Age(81-100Yrs) |
4.245800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.343700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.265800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.667800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.205400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.933200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.950200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.957700E-02 |
| Classical-VS-Follicular |
5.012800E-01 |
| Classical-VS-Other |
8.993800E-01 |
| Classical-VS-Normal |
7.083500E-03 |
| Tall-VS-Follicular |
2.924800E-01 |
| Tall-VS-Other |
4.098600E-01 |
| Tall-VS-Normal |
6.588600E-04 |
| Follicular-VS-Other |
9.134400E-01 |
| Follicular-VS-Normal |
1.003760E-02 |
| Other-VS-Normal |
1.995250E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.604600E-03 |
| Normal-vs-N1 |
7.031300E-04 |
| N0-vs-N1 |
3.298400E-01 |
|
|
